Atlas Trials

Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study

Clinical trial NCT02454530 · TERMINATED

Trial details

NCT number
NCT02454530
Sponsor
Pfizer
Status
TERMINATED
Study type
OBSERVATIONAL
Chemotherapy-Induced Neutropenia
Start date
2014-09-01
Primary completion
2016-10-18
Enrollment
1160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.